Business
Half-year Report
Half-year Report.
About this update from Hellenic Dynamics Plc
[{"type":"text","content":"\n\n28 December 2023\n \nHellenic Dynamics Plc\n \n(\"HELD\" or \"the Company\")\n \nInterim Results for the six months ended 30 September 2023\nLondon, 28 December 2023: Hellenic Dynamics Plc (LSE: HELD), a medical cannabis cultivator with a dedicated focus on producing tetrahydrocannabinol (\"THC\") dominant strains of medical cannabis flowers for the fast growing global medical cannabis markets, announces its half-yearly results for the six months ended 30 September 2023 (the \"Period\") .\nOperational highlights for the period\n· Received a European Union grant of EUR €304,425 via the EU Horizon Europe project, as the only medical cannabis cultivator. The overall budget for this EU Horizon Europe is just under EUR €9 million over a period of 36 months. Hellenic Dynamics consortium consists of 29 partners from 11 countries including Kingston University, Queen Mary University of London, and Fujitsu Technology solutions\n· Entered into a five-year memorandum of understanding (\"MoU\") with ELGO-DIMITRA, the Institute of Plant Breeding and Genetic Resources, a public sector entity functioning under the Greek Ministry of Agriculture, Development and Food located near Thessaloniki, Greece. The MOU set out the intentions of ELGO-DIMITRA and the Company to collaborate on future projects and research, including the registration of medical cannabis genetics for European intellectual property (\"IP\") ownership\n· Developed and implemented the Company's Product Outsourcing and Development (\"POD\") cultivation strategy and signed an MOU with Demecan Holdings, a trading name of Deutsche Medizinalcannabis GmbH, for the cultivation and supply of medical cannabis flowers\n· Signed an exclusive agreement with Nine Lions Bioscience Corp, a renowned Canadian-based supplier of cannabis genetics, for the exclusive European cultivation of unique high THC medical cannabis flowers\n· Successfully passed all resolutions with an average of 99.93% of votes at the enlarged Company's first Annual General Meeting, including the re-appointment of all directors\n \nOperational highlights for post period-end\n· Completed the construction of the Company's...